- ►annals.org [PDF] JM Inadomi, R Sampliner, J Lagergren, D … - Annals of internal medicine, 2003 - Am Coll Physicians Background: Once-in-a-lifetime screening for Barrett esophagus has been proposed
for patients with gastroesophageal reflux dis- ease (GERD), but there is little
evidence of its cost-effectiveness. Objective: 1) To determine the cost- ... Cited by 191 - Related articles - BL Direct - All 6 versions
DA Corley, TR Levin, LA Habel, NS Weiss, PA … - Gastroenterology, 2002 - Elsevier BE was diagnosed in 135 of 589 adenocarcinoma patients, with 23 BE patients
diagnosed greater than 6 months before cancer was diagnosed. Among these 23
patients, 73% of the surveillance-detected cancer patients (n = 15) were ... Cited by 239 - Related articles - BL Direct - All 10 versions
D Provenzale, C Schmitt, JB Wong… - The American journal of gastroenterology, 1999 - sadieo.ucsf.edu OBJECTIVE: Surveillance of Barrett's patients is recommended, to detect
dysplasia and early cancer. The reported risk for developing cancer varies
substantially, however. Our previous analysis used an average cancer ... Cited by 251 - Related articles - View as HTML - BL Direct - All 8 versions
- ►isa-geek.com [PDF] D Sources, T Horizon, O Measure - Ann Intern Med, 2003 - Am Coll Physicians Background: Once-in-a-lifetime screening for Barrett esophagus has been proposed
for patients with gastroesophageal reflux dis- ease (GERD), but there is little
evidence of its cost-effectiveness. Objective: 1) To determine the cost- ... Related articles - All 3 versions
A Sonnenberg, A Soni, RE Sampliner - Alimentary Pharmacology and Therapeutics, 2002 - sonnenberg2.tripod.com In a subgroup of patients with gastro-oesophageal reflux disease, the normal
squamous epithelium of the distal oesophagus is replaced by columnar lined
epithelium with intestinal metaplasia. The condition of intestinal ... Cited by 52 - Related articles - View as HTML - BL Direct - All 5 versions
A Soni, RE Sampliner, A Sonnenberg - The American journal of gastroenterology, 2000 - nature.com Using an incremental cost-effectiveness ratio as outcome measure, the
cost-effectiveness of endoscopic screening was compared to not screening in a
decision tree. It was assumed that GERD patients at age 60 yr undergo a ... Cited by 77 - Related articles - BL Direct - All 6 versions
DK Rex, OW Cummings, M Shaw, MD Cumings … - Gastroenterology, 2003 - Elsevier : The population prevalence of Barrett's esophagus (BE) is uncertain. Our aim
was to describe the prevalence of BE in a volunteer population. : Upper
endoscopy (EGD) was performed in 961 persons with no prior history of EGD ... Cited by 162 - Related articles - BL Direct - All 10 versions
JH Rubenstein, N Vakil, JM Inadomi - Alimentary Pharmacology and Therapeutics, 2005 - medscape.com The annual incidence of oesophageal adenocarcinoma (EAC) in the United States is
approximately 6 500 and rising faster than any other cancer. [1-3] Patients
presenting with symptomatic EAC typically have advanced disease, and those ... Cited by 6 - Related articles - BL Direct - All 6 versions
JH Rubenstein, JM Inadomi - Journal of clinical gastroenterology, 2006 - journals.lww.com Background: Diagnosing a potentially life-threatening disease may adversely
affect patient quality of life (QOL) independent of biologic effects. It is
unknown whether the mere diagnosis of Barrett's esophagus (BE) adversely ... Cited by 4 - Related articles - BL Direct - All 3 versions
- ►researchcore.org [PDF] GS Dulai, S Guha, KL Kahn, J Gornbein, WM … - Gastroenterology, 2002 - Elsevier The low prior prevalence ( 5%) of Barrett's esophagus in this study population
provides indirect evidence to suggest that recent efforts to identify patients
with Barrett's—whether through endoscopic screening or evaluation of ... Cited by 142 - Related articles - BL Direct - All 13 versions
